A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2004
11/17/2004	EP1476120A2 Treatment methods using anti-cd22 antibodies
11/17/2004	EP1476067A2 Novel compositions and methods for cancer
11/17/2004	EP1476018A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
11/17/2004	EP1362045B1 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/17/2004	EP1289999B1 Antitumoral analogs of et-743
11/17/2004	EP1286990B1 Stolonoxides
11/17/2004	EP1283672B1 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin"
11/17/2004	EP1274700B1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders
11/17/2004	EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004	EP1257261B1 Antiviral pharmaceutical compositions containing iron chelators
11/17/2004	EP1254229B1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
11/17/2004	EP1252322B1 Herpes virus strains for gene therapy
11/17/2004	EP1250340B1 Methods and compounds for inhibiting mrp1
11/17/2004	EP1242413B1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels
11/17/2004	EP1176968B1 Selenium-containing pro-drugs for cancer therapy
11/17/2004	EP1156999B1 Method for the preparation of a chiral-beta-amino ester
11/17/2004	EP1154803B1 Immobilized labeling compounds and methods
11/17/2004	EP1144409B1 Phenyl urea and phenyl thiourea derivatives
11/17/2004	EP1098885B1 Imidazole compounds and their use as adenosine deaminase inhibitors
11/17/2004	EP1073733B1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
11/17/2004	EP1073469B1 Stable mitoxantron solutions
11/17/2004	EP1054994B1 Fermentative preparation process for cytostatics and crystal forms thereof
11/17/2004	EP0981369B1 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
11/17/2004	EP0731811B1 Chaperonin 10
11/17/2004	EP0679160B1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
11/17/2004	CN1547617A Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof
11/17/2004	CN1547613A Method of estimating the risk of expression of adverse drug reaction caused by the administration of a compound, which is either metabolized per se by UGT1A1 enzyme or whose metabolic intermediate is
11/17/2004	CN1547590A Humanized anti-LT-beta-R antibodies
11/17/2004	CN1547586A Increased recovery of active proteins
11/17/2004	CN1547583A 多环鸟嘌呤磷酸二酯酶v抑制剂 Polycyclic guanine phosphodiesterase inhibitor v
11/17/2004	CN1547477A Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
11/17/2004	CN1547471A Combination comprising combretastatin and anticancer agents
11/17/2004	CN1547469A Paclitaxel mixed composition and water-in-oil type emulsion formulation for chemoembolization and preparation method thereof
11/17/2004	CN1547466A Extended release oral dosage form
11/17/2004	CN1547464A Prolonged release bioadhesive therapeutic systems
11/17/2004	CN1546664A Monoclonal antibody CAb-1 heavy and light chain variable region gene of human carcinoma of large intestine, and its uses
11/17/2004	CN1546662A Recombinant caspase-6 gene having target activity and its uses in treating tumor
11/17/2004	CN1546533A Hericium erinaceus sulfate proteoglycan, preparation method thereof and pharmaceutical compositions with the same as active component
11/17/2004	CN1546531A Polysaccharide, preparation and use thereof
11/17/2004	CN1546528A Fusion protein of kininogen D5 and tumor necrosis factor related apoptosis-inducing ligand(D5-TRAIL), its preparation and use thereof
11/17/2004	CN1546527A Light and heavy chain variable region genes of monoclonal antibody CAb-2 against human colorectal carcinoma and their application
11/17/2004	CN1546522A Alkaline fibroblast growth factor antigen epitope peptide and its screening method
11/17/2004	CN1546519A Method for extracting antineoplastic components in ganoderma lucidum triterpene
11/17/2004	CN1546518A Solasodine salt of organic acid, its preparation method and application in medicine
11/17/2004	CN1546494A Tricycloacetal lactones ,preparing process and use thereof
11/17/2004	CN1546486A Pterocarya stenoptera extract, its preparation and use
11/17/2004	CN1546472A Pyridyl alkane acid amides as cytostatics and immunosupressives
11/17/2004	CN1546451A Hydroxyanthraquinone derivatives and their application in preparation of anticancer medicines
11/17/2004	CN1546385A Ferric oxide with high magnetic-hysteresis heat generation ability for the use of tumour thermomagnetic therapy and method for preparing the same
11/17/2004	CN1546173A Anticancer nanometer targeted administered prescription
11/17/2004	CN1546168A Preparing method of liposome endothelial chalone
11/17/2004	CN1546158A Specific medicine for treating cancer and preparing process
11/17/2004	CN1546155A Anticancer Chinese traditional medicine
11/17/2004	CN1546152A Freeze-dried 'Shenqifuzheng' powder for injection and its preparing process
11/17/2004	CN1546151A Freeze-dried 'Shenqifuzheng' powder for injection and its preparing process
11/17/2004	CN1546146A Chinese traditional medicine preparation for treating leucocythemia and solid tumor
11/17/2004	CN1546138A Specific medicine for treating esophagus cancer
11/17/2004	CN1546090A Anticancer Chinese traditional medicine preparation and preparation process and application thereof
11/17/2004	CN1546068A Modified technique for making zedoary turmeric oil and glucose injection
11/17/2004	CN1546059A Arsenic trioxide oral liquid and its preparation process
11/17/2004	CN1546058A Freeze dried arsenic trioxide injection and its preparation process
11/17/2004	CN1546055A Anticancer Xiaoaiping injection and its preparation
11/17/2004	CN1546041A Ursolic acid dripping pills and its preparation process
11/17/2004	CN1546040A Compisition as substitution of phthalocyanine cooperator and low density lipoprotein and its preparation process
11/17/2004	CN1176137C Multi-arm fork type functional polyethylene glycol preparation method and its application in medicine
11/17/2004	CN1176103C Antineoplastic compound Intercedenside C in Sea Cucumber Mensamaria Intercedens
11/17/2004	CN1176102C Triterpenoid, its preparation method and drug composition using the same as active component
11/17/2004	CN1176099C Natural dissociation essence Gamma gene and antineoplastic active polypeptide dissociation essence Gamma
11/17/2004	CN1176072C Vitamin D3 analogs
11/17/2004	CN1176067C Anti-tumor 2-amino-carbonyl-1,2-di (methylsulfonyl)-1-(substituted) diazane
11/17/2004	CN1175899C Medicine composition and preparation and use thereof
11/17/2004	CN1175897C Malignant tumor treating medicine
11/17/2004	CN1175888C Er Beimu Capsule and its preparing process thereof
11/17/2004	CN1175882C Anticancer dietary medicine composition and its preparation method
11/17/2004	CN1175879C Medicine for treating pain syndrome of late cancer and its preparation
11/17/2004	CN1175876C Antineoplastic Chinese traditional medicine
11/17/2004	CN1175868C Powder preparation for stopping pain and dispersing swelling
11/17/2004	CN1175864C Production process of cancer-eliminating pearl powder
11/17/2004	CN1175848C Cancer preventing and treating Chinese herbal medicine and its preparation process
11/17/2004	CN1175823C Arsenic sulfide compounds and derivatives thereof for cancer treatment
11/17/2004	CN1175819C Application of hydrochloric acid in preparing medicine for tumor
11/16/2004	US6818764 Process for preparing substance GM-95
11/16/2004	US6818758 Estrogen receptor beta variants and methods of detection thereof
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818667 Obtained by fermenting the microorganism eurotium echinulatum delacroix (dsm 13872); inhibitors of kdr kinase, antiangiogenic agents suitable for preventing and/or treating malignant diseases
11/16/2004	US6818664 Antitumor agent which comprises said compound or a physiologically acceptable salt thereof as an active ingredient.
11/16/2004	US6818663 As inhibitors of cyclin-dependent kinase 4 (cdk4); antiproliferative agents; for therapy of cancer, tumors
11/16/2004	US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
11/16/2004	US6818652 Heterocyclic retinoid compounds
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818630 Biologically active materials
11/16/2004	US6818622 Selective MMP inhibitors having reduced side-effects
11/16/2004	US6818621 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/16/2004	US6818615 Antitumor, anticancer agents; synergistic mixture
11/16/2004	US6818419 IRAK-4: compositions and methods of use
11/16/2004	US6818230 Antiproliferative effect can be achieved by subjecting conditioned medium obtained by culturing the structures of the invention in culture medium to filtration; anticancer agents
11/16/2004	US6818214 Modulating cell proliferation or apoptosis comprising modulating psoriastatin activity
11/16/2004	CA2145383C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
11/11/2004	WO2004096851A1 Galectin 9-inducing factor

1 ... 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 ... 2211